CILIA
发表于 2025-3-21 18:34:02
书目名称RNA Interference and Cancer Therapy影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0820171<br><br> <br><br>书目名称RNA Interference and Cancer Therapy影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0820171<br><br> <br><br>书目名称RNA Interference and Cancer Therapy网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0820171<br><br> <br><br>书目名称RNA Interference and Cancer Therapy网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0820171<br><br> <br><br>书目名称RNA Interference and Cancer Therapy被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0820171<br><br> <br><br>书目名称RNA Interference and Cancer Therapy被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0820171<br><br> <br><br>书目名称RNA Interference and Cancer Therapy年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0820171<br><br> <br><br>书目名称RNA Interference and Cancer Therapy年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0820171<br><br> <br><br>书目名称RNA Interference and Cancer Therapy读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0820171<br><br> <br><br>书目名称RNA Interference and Cancer Therapy读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0820171<br><br> <br><br>
Antioxidant
发表于 2025-3-21 21:42:40
siRNA-Based Drug Targeting Human Bcl-xL Against Cancers, to functionally deliver tumor-specific siRNA molecules in nude mice. Here, we introduce an orthotopic tumor inoculation model in nude mice: the resulting orthotopic tumors more closely replicate the clinical conditions in humans—including the metastasis mode—than ectopic subcutaneously inoculated tumors.
deactivate
发表于 2025-3-22 04:23:07
,Design Strategy to Access siRNA-Encapsulating DNA “Nanosuitcases” That Can Conditionally Release Thstrategies. We present an overview of the design strategy used to access these DNA nanostructures, followed by the steps involved in DNA sequence generation, assembly, and validation of this construct.
褪色
发表于 2025-3-22 06:13:07
http://reply.papertrans.cn/83/8202/820171/820171_4.png
apiary
发表于 2025-3-22 12:15:06
,Preparation of a Carrier to Achieve In Vivo Delivery of siRNA: The Example of Chitosan-Coated Poly(e nanoparticles with the siRNA can be achieved by performing an association yield above 90% using a mass ratio of 1 mg siRNA/50 mg of nanoparticles (20 μg siRNA/mg nanoparticles, 1 nmol siRNA (. 14 kDa)/mg nanoparticles).
gerontocracy
发表于 2025-3-22 14:52:31
http://reply.papertrans.cn/83/8202/820171/820171_6.png
dendrites
发表于 2025-3-22 17:51:57
http://reply.papertrans.cn/83/8202/820171/820171_7.png
angiography
发表于 2025-3-23 00:50:28
Combinatorial siRNA Polyplexes for Receptor Targeting,de a brief background on the formulation design and detailed protocols to evaluate polyplex formation, gene silencing efficiency, and receptor-directed cell killing in cancer cells using targeted combinatorial siRNA polyplexes.
Pigeon
发表于 2025-3-23 02:27:52
Systemic Modulation of Lymphocyte Subsets Using siRNAs Delivered via Targeted Lipid Nanoparticles,nduce therapeutic gene silencing. This approach utilizes antibodies that decorate lipid nanoparticle surfaces to home into lymphocyte subsets. This approach opens new avenues for discovery of new drug targets and potentially for therapeutics.
Charade
发表于 2025-3-23 07:00:59
Silencing PRDM14 via Oligonucleotide Therapeutics Suppresses Tumorigenicity and Metastasis of Breasuced the size of tumors and lung metastases in nude mice. In this chapter, we introduce the concept and methods to develop and apply systematically injected small interfering RNA therapy for breast cancer models in vivo.